Literature DB >> 2458319

Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis.

J J Kim1, R E Mandrell, Z Hu, M A Westerink, J T Poolman, J M Griffiss.   

Abstract

We studied the lipooligosaccharides (LOS) of 28 group A Neisseria meningitidis of epidemiologically diverse origins to investigate whether each of the LOS serotypes found in serogroup A could be identified physically as well as antigenically. Using a dot blot assay with LOS-specific monoclonal antibodies (MAbs), we identified four epitopes that were serotype specific. The LOS from strains of each serotype were electromorphically and antigenically distinct when analyzed by silver-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. The LOS of L8 strains contained a 3,600-Mr component that bound the L8 MAb. The LOS of L9 strains contained two major components of 4,500 and 4,200 Mr. They bound the L9 MAb to the larger component. The LOS of L10 strains had a single major component of 4,000 Mr that bound the L10 MAb. The LOS of L11 strains contained a major 3,600-Mr component that could not be distinguished from the 3,600-Mr LOS of L8 strains by SDS-PAGE but that bound the L11 MAb. LOS of group A strains contained a highly conserved epitope in addition to a serotype-specific epitope. This was identified by a MAb that bound to all the strains on dot-blots and to multiple LOS components of various Mrs on immunoblots. We conclude that the LOS which bear the L9, L10, and L11 determinants are physically distinct and can be identified by SDS-PAGE or MAb binding or both. L8 and L11 are both borne on a 3.6-kilodalton LOS and can only be distinguished serologically.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458319      PMCID: PMC259622          DOI: 10.1128/iai.56.10.2631-2638.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Prevalence of meningococcal serogroups and description of three new groups.

Authors:  J R Evans; M S Artenstein; D H Hunter
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

2.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Response to antigenic determinants of Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay.

Authors:  M A Bertram; J M Griffiss; D D Broud
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

4.  Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964-70.

Authors:  M S Artenstein; H Schneider; M D Tingley
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  Monoclonal antibody analysis of lipopolysaccharide from Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  M A Apicella; K M Bennett; C A Hermerath; D E Roberts
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Epidemiological value of lipopolysaccharide and heat-modifiable outer-membrane protein serotyping of group-A strains of Neisseria meningitidis.

Authors:  J M Griffiss
Journal:  J Med Microbiol       Date:  1982-08       Impact factor: 2.472

7.  Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates.

Authors:  L F Mocca; C E Frasch
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

Review 8.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

10.  Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland.

Authors:  H Peltola
Journal:  Scand J Infect Dis       Date:  1978
View more
  27 in total

1.  Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44.

Authors:  Y Tong; V Reinhold; B Reinhold; B Brandt; D C Stein
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.

Authors:  M M Estabrook; J M Griffiss; G A Jarvis
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.

Authors:  T J Inzana; J Hensley; J McQuiston; A J Lesse; A A Campagnari; S M Boyle; M A Apicella
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

4.  Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b.

Authors:  C C Patrick; S E Pelzel; E E Miller; E Haanes-Fritz; J D Radolf; P A Gulig; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils.

Authors:  M M Estabrook; D Zhou; M A Apicella
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

6.  Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.

Authors:  R M Hamadeh; M M Estabrook; P Zhou; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 9.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

10.  Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS.

Authors:  A L Erwin; R E Mandrell; R S Munford
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.